 | • レポートコード：MRC2302D045 • 出版社/出版日：Transparency Market Research / 2022年12月26日 • レポート形態：英語、PDF、208ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医薬品 |
| Single User | ￥811,300 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,231,300 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,651,300 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の市場調査レポートは、2022年に705.5百万ドルであった世界の歯科用麻酔薬市場規模が2031年には904.1百万ドルとなり、予測期間の間に年平均2.6％増加すると展望しています。当レポートでは、歯科用麻酔薬の世界市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、麻酔種類別（局所麻酔、全身麻酔、鎮静剤）分析、投与経路別（経口、静脈内、その他）分析、エンドユーザー別（病院、歯科医院、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競合状況などの項目をまとめました。並びに、当レポートに記載されている企業情報には、3M、Aspen Group、Centrix, Inc.、Crosstex International, Inc. 、Dentalhitec、Dentsply Sirona、Laboratorios Inibsa、Laboratorios Normon、Pierrel SPA、Primex Pharmaceuticals、Septodont、Zeyco、Southern Anesthesia & Surgical, Inc.、Milestone Scientificなどが含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界の歯科用麻酔薬市場規模：麻酔種類別 - 局所麻酔の市場規模 - 全身麻酔の市場規模 - 鎮静剤の市場規模 ・世界の歯科用麻酔薬市場規模：投与経路別 - 経口投与における市場規模 - 静脈内投与における市場規模 - その他投与における市場規模 ・世界の歯科用麻酔薬市場規模：エンドユーザー別 - 病院における市場規模 - 歯科医院における市場規模 - その他エンドユーザーにおける市場規模 ・世界の歯科用麻酔薬市場規模：地域別 - 北米の歯科用麻酔薬市場規模 - ヨーロッパの歯科用麻酔薬市場規模 - アジア太平洋の歯科用麻酔薬市場規模 - 中南米の歯科用麻酔薬市場規模 - 中東・アフリカの歯科用麻酔薬市場規模 ・競合状況 |
Dental Anesthetics Market – Scope of Report
TMR’s report on the global dental anesthetics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global dental anesthetics market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dental anesthetics market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the dental anesthetics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dental anesthetics market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global dental anesthetics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dental anesthetics market.
The report delves into the competitive landscape of the global dental anesthetics market. Key players operating in the global dental anesthetics market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global dental anesthetics market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market dental anesthetics.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dental Anesthetics Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dental Anesthetics Market Analysis and Forecast, 2017–2031
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Insights on number of dental surgical procedures
5.2. Regulatory Scenario by Region/Globally
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Dental Anesthetics Market Analysis and Forecast, by Type of Anesthesia
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type of Anesthesia, 2017–2031
6.3.1. Local Anesthesia
6.3.1.1. Articaine
6.3.1.2. Bupivacaine
6.3.1.3. Lidocaine
6.3.1.4. Others
6.3.2. General Anesthesia
6.3.3. Sedation
6.4. Market Attractiveness Analysis, by Type of Anesthesia
7. Global Dental Anesthetics Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Route of Administration, 2017–2031
7.3.1. Oral
7.3.2. Intravenous
7.3.3. Others
7.4. Market Attractiveness Analysis, by Route of Administration
8. Global Dental Anesthetics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Dental Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Dental Anesthetics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America (LATAM)
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Dental Anesthetics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
10.2.1. Local Anesthesia
10.2.1.1. Articaine
10.2.1.2. Bupivacaine
10.2.1.3. Lidocaine
10.2.1.4. Others
10.2.2. General Anesthesia
10.2.3. Sedation
10.3. Market Value Forecast, by Route of Administration, 2017–2031
10.3.1. Oral
10.3.2. Intravenous
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Dental Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type of Anesthesia
10.6.2. By Route of Administration
10.6.3. By End-user
10.6.4. By Country
11. Europe Dental Anesthetics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
11.2.1. Local Anesthesia
11.2.1.1. Articaine
11.2.1.2. Bupivacaine
11.2.1.3. Lidocaine
11.2.1.4. Others
11.2.2. General Anesthesia
11.2.3. Sedation
11.3. Market Value Forecast, by Route of Administration, 2017–2031
11.3.1. Oral
11.3.2. Intravenous
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Dental Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type of Anesthesia
11.6.2. By Route of Administration
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Dental Anesthetics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
12.2.1. Local Anesthesia
12.2.1.1. Articaine
12.2.1.2. Bupivacaine
12.2.1.3. Lidocaine
12.2.1.4. Others
12.2.2. General Anesthesia
12.2.3. Sedation
12.3. Market Value Forecast, by Route of Administration, 2017–2031
12.3.1. Oral
12.3.2. Intravenous
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Dental Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type of Anesthesia
12.6.2. By Route of Administration
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Dental Anesthetics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
13.2.1. Local Anesthesia
13.2.1.1. Articaine
13.2.1.2. Bupivacaine
13.2.1.3. Lidocaine
13.2.1.4. Others
13.2.2. General Anesthesia
13.2.3. Sedation
13.3. Market Value Forecast, by Route of Administration, 2017–2031
13.3.1. Oral
13.3.2. Intravenous
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Dental Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type of Anesthesia
13.6.2. By Route of Administration
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Dental Anesthetics Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type of Anesthesia, 2017–2031
14.2.1. Local Anesthesia
14.2.1.1. Articaine
14.2.1.2. Bupivacaine
14.2.1.3. Lidocaine
14.2.1.4. Others
14.2.2. General Anesthesia
14.2.3. Sedation
14.3. Market Value Forecast, by Route of Administration, 2017–2031
14.3.1. Oral
14.3.2. Intravenous
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Dental Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Type of Anesthesia
14.6.2. By Route of Administration
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Dentsply Sirona
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Laboratorios Inibsa
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Pierrel SPA
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Septodont
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Laboratorios Normon
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Primex Pharmaceuticals
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Aspen Group
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Dentalhitec
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Zeyco
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Crosstex International, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Centrix, Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. 3M
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Southern Anesthesia & Surgical, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Milestone Scientific
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview